CORD-19:775b90287b44353bee979abb0970a4666022f86d / 786232-786539 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Improvement was significantly greater with BDP nasal aerosol (80 mg/day) than with placebo over the first 6 wk of treatment in children 6-11 y of age in average am and pm rTNSS and iTNSS (mean [95% CI] treatment difference: -0.66 [-1.08, -0.24], P = 0.002 and -0.58 [-0.99, -0.18], P = 0.004, respectively).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T12871","span":{"begin":0,"end":307},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T12871","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T64","span":{"begin":0,"end":307},"obj":"Sentence"}],"attributes":[{"subj":"T64","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#d9ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#e493ec"}]}]}}